Abbott

It's the first victory for the companies as they face more than 1,000 similar cases and both have previously lost trials, including one that ended with an almost US$500 million verdict against Abbott in July.

Abbott, Reckitt unit defeat claims in baby formula trial

The jury deliberated for less than a day before clearing them of responsibility for causing necrotising enterocolitis

Illinois resident Margo Gill, who brought the case against Abbott, alleged that the company failed to warn that its formula could cause a potentially deadly disease called necrotizing enterocolitis (NEC) in premature babies.

Abbott must pay US$495 million in premature infant formula trial, jury finds

A JURY on Friday found that Abbott Laboratories’ specialised formula for premature infants caused an Illinois girl to develop a dangerous bowel disease, ordering the healthcare company to pay US$495 m...

Sales of Abbott's medical devices rose 10.2 per cent to US$4.66 billion, beating the average estimate.

Abbott raises annual profit forecast as strong medical device sales power quarterly beat

The company now expects a profit of US$4.61 to US$4.71 per share for the full year

The devices, one for the health-conscious and another for those with diabetes, follow Abbott’s FreeStyle Libre, which generates over US$1 billion every quarter and is sold under prescription for patients with diabetes.

Abbott secures FDA clearance for two over-the-counter glucose monitors

ABBOTT Laboratories said on Monday (Jun 11) the US health regulator had cleared the company’s two new over-the-counter glucose monitoring devices, expanding its presence in a fast-growing, multi-billi...

Profit rose to 2.87 billion rupees (S$46.5 million) for the three months ended March 31, from 2.31 billion rupees a year earlier.

Drugmaker Abbott India posts Q4 profit rise on higher sales

The company said its revenue from operations rose 7% to 14.39 billion rupees in the fourth quarter

Sales of Abbott’s medical devices have been strengthened in recent quarters due to a resurgence in the demand for joint replacements as well as other surgeries that were delayed during the Covid-19 pandemic.

Abbott beats quarterly profit estimates on strong medical device sales

ABBOTT Laboratories beat Wall Street estimates for quarterly profit on Wednesday (Apr 17) and raised the lower end of its forecast, as robust demand for medical procedures boosted sales of its devices...

Abbott says the protein shake is first among the range of products lined up to be launched under its new brand, called Protality.

Abbott launches protein shake brand to help people on weight-loss drug

ABBOTT Laboratories said on Wednesday (Jan 31) it has launched a new protein shake that would help adults looking to lose weight and maintain their muscle mass.

Abbott posted a near 17 per cent rise in quarterly sales of its medical devices to US$4.25 billion, beating analysts’ estimates of US$4.16 billion.

Abbott profit up on strong sales of medical devices, diagnostics

Abbott Laboratories on Wednesday (Oct 18) tightened its profit forecast for the year after beating estimates for third-quarter earnings on strong demand for its medical devices and diagnostics product...

Abbott's utilities excellence team oversees the plant’s energy management system, and several of its members have undertaken the Singapore Certified Energy Manager training.
ENERGY EFFICIENCY NATIONAL PARTNERSHIP

Abbott’s Singapore nutrition facility gets a green thumbs up

Since 2018, healthcare group Abbott’s nutrition facility in Singapore has invested in eight significant projects as part of its pursuit of energy efficiency. These initiatives included the installatio...